Auckland hospital patients wrongly told they had sexually transmitted infections
That first false positive was identified on June 4. A total of four faulty batches was then discovered.…
In Transylvania, fear haunts Romania’s troubled democracy – POLITICO
“There is a lot of hate in this campaign. I have received threats personally, and been told pro-Europeans…
Akido Raises $60 Million Series B to Expand Reach of ScopeAI, its Breakthrough Health Artificial Intelligence
Akido’s ScopeAI is a first-of-its-kind system that fully integrates AI into a provider visit LOS ANGELES, May 15,…
As a patient, I don’t want my doctor to use an AI scribe
“Yes,” I said reluctantly to the urgent care provider who entered the exam room to see me that…
How I went from AI scribe skeptic to fan
Two decades ago, when I first began practicing emergency medicine, patient documentation was a manual process. I would…
Belgium wanted a drug shortages bill. It’s not happy with the EU’s plan. – POLITICO
While he acknowledged the act is an “important step forward,” he added that the “proposed funding is insufficient,…
Merz won the German election. Here’s what it means for Europe. – POLITICO
Welcome, Willkommen, to POLITICO’s German election liveblog, where we’re bringing you real-time updates as results come in. Conservative leader…
UAB’s Spain Rehabilitation Center debuts new facility dog
BIRMINGHAM, Ala. (WBRC) – UAB’s Spain Rehabilitation Center has a new colleague walking the halls…Topgun is a two-year-old…
Hippocratic AI raises $141M for creating patient-facing AI agents
Hippocratic AI, a startup building AI solutions that can handle non-diagnostic patient-facing tasks, secured a massive $141 million…
A new era for disease management?
Effective management of atopic dermatitis (AD) has been one of the top priorities for physicians over the years,…
France extends medical cannabis trial to help patients find alternatives
French health authorities have extended a medical cannabis experiment until 31 July 2025, giving 1,800 patients more time…
Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union
INCHEON, South Korea, December 15, 2024–(BUSINESS WIRE)–Celltrion today announced that the Committee for Medicinal Products for Human Use…